YieldMax Short TSLA Option Income Strategy ETFCRSH

CRSH is the YieldMax Short TSLA Option Income Strategy ETF , a wrapper that sells monthly option premium on a 1x short exposure to Tesla, all packaged in a daily-traded ETF that still looks like it is trying to decide whether it is a hedge fund or a ticker.

The fund’s Nasdaq blotter shows thin turnover and wide spreads since listing, which is market-speak for “liquidity is polite and the crowd is still auditioning.” The SEC filing confirms the mandate but offers no disclosure on the average Greeks, gap risk, or worst-case Tesla tantrum; the 1.11% expense ratio, however, is locked and loaded. That single figure is the fund’s loudest argument and quietest risk: every lag begins here, not with Tesla’s next earnings surprise.

The SEC EDGAR entry for CRSH is broadly a doorway: it lists the wrapper, the exchange, and the fee, but the filing stops short of telling us how often the short options bleed when TSLA gaps or how much premium decay the strategy must claw back to break even. The glamour slide deck says “harvest income,” the filing says “1.11% per year, no waivers,” and the Nasdaq blotter says “sell it if the source requires readers to.”

For a fund that trades on the theme of “earn while the stock goes nowhere,” the evidence so far is that the stock still goes somewhere, the liquidity is still polite, and the fee is absolutely real. The FINRA fund analyzer confirms the 1.11% charge and the monthly rebalancing cadence, which in a short-options sleeve means rolling short puts or calls and hoping the premium covers the delta bleed. The distance between the marketing slide and the accounting line is the fund’s actual product.

What we do not know: the average option greeks, the worst-case gap risk, the realised decay versus spot drift, and whether the premium harvest actually survives a Tesla headline that moves the stock before the 10 a.m. ET options close. The evidence we have is the wrapper, the fee, the exchange, and the thin blotter; everything else is inference until the next filing or a product-level disclosure that the fund chooses to provide.